Search

Displaying results 1711 - 1720 of 9686 in total
  1. Drug

    Amfonelic acid

    go.drugbank.com/drugs/DB21147
    Experimental

    Amfonelic acid is a small molecule drug. Amfonelic acid has a monoisotopic molecular weight of 308.12 Da.

  2. Drug

    Xanoxic acid

    go.drugbank.com/drugs/DB21173
    Experimental

    Xanoxic acid is a small molecule drug. Xanoxic acid has a monoisotopic molecular weight of 298.08 Da.

  3. Drug

    Tizoprolic acid

    go.drugbank.com/drugs/DB21293
    Experimental

    Tizoprolic acid is a small molecule drug. Tizoprolic acid has a monoisotopic molecular weight of 171.04 Da.

  4. Drug

    Hydroxytoluic acid

    go.drugbank.com/drugs/DB21441
    Experimental

    Hydroxytoluic acid is a small molecule drug. Hydroxytoluic acid has a monoisotopic molecular weight of 152.05 Da.

  5. Drug

    Pregabalin naproxencarbil

    go.drugbank.com/drugs/DB21744
    Experimental

    Pregabalin naproxencarbil is a small molecule drug. Pregabalin naproxencarbil has a monoisotopic molecular weight of 459.23 Da.

  6. Drug

    anti-OX40 antibody BMS 986178

    go.drugbank.com/drugs/DB15773
    Investigational

    A macrocyclic peptide (BMS-986189) with activity in binding and functional assays comparable to a PD-L1 antibody.

  7. Drug

    Abatacept

    go.drugbank.com/drugs/DB01281
    ApprovedInvestigational

    [L20504,L42715] Structurally, abatacept is a glycosylated fusion protein with a MALDI-MS molecular weight of 92,300 Da and it is a homodimer of two homologous polypeptide chains of 357 amino acids each … The drug has activity as a selective co-stimulation modulator with inhibitory activity on T lymphocytes.

  8. Drug

    Iomethin I-125

    go.drugbank.com/drugs/DB20779
    Experimental

    Iomethin I-125 is a small molecule drug. Iomethin I-125 has a monoisotopic molecular weight of 353.05 Da.

  9. Drug

    Lofexidine

    go.drugbank.com/drugs/DB04948
    ApprovedInvestigational

    Lofexidine is a non-opioid centrally acting alpha2-adrenergic receptor agonist that was first approved for the treatment of opioid withdrawal in the United Kingdom in 1992.

  10. Drug

    LP-2307

    go.drugbank.com/drugs/DB17470
    Experimental

    LP-2307 is an investigational allogeneic large multivalent immunogen (LMI) vaccine developed by Avanir. It was investigated for melanoma.

    Synonyms: LP 2307